News & Events

Medchemfarma has been beneficiary in the call for start-up capital grants for emerging technology companies for the year 2023, through Acció Program (https://accio.gencat.cat) to carry out the Project: New cancer treatments based on covalent kinase inhibitors as immuno-oncological therapies (ACE087/23/000052)

Medchemfarma has got access to funds through the support of the Ministerio de Ciencia, Innovación y Universidades, Next Generation EU funds and from the Recovery, Transformation and Resilience Plan, (call 2022) to execute the following Project: Discovery and preclinical development…